187 related articles for article (PubMed ID: 36542951)
1. Mesoporous polydopamine-based nanoplatform for enhanced tumor chemodynamic therapy through the reducibility weakening strategy.
Zhang Q; Xu X; Yang Q; Duan Y; Chen C; Zhao S; Ouyang Y; Chen Y; Cao Y; Liu H
Colloids Surf B Biointerfaces; 2023 Feb; 222():113091. PubMed ID: 36542951
[TBL] [Abstract][Full Text] [Related]
2. Ultrasmall Gold-Coated Mesoporous Polydopamine Nanoprobe to Enhance Chemodynamic Therapy by Self-Supplying H
Wang Z; Shi Y; Shi Y; Zhang J; Hao R; Zhang G; Zeng L
ACS Appl Mater Interfaces; 2022 Dec; 14(49):54478-54487. PubMed ID: 36448730
[TBL] [Abstract][Full Text] [Related]
3. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer.
Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J
ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO
Wang Z; Li Z; Shi Y; Zeng L
Regen Biomater; 2023; 10():rbad087. PubMed ID: 37936892
[TBL] [Abstract][Full Text] [Related]
5. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
[TBL] [Abstract][Full Text] [Related]
6. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
7. Dual-responsive and NIR-driven free radical nanoamplifier with glutathione depletion for enhanced tumor-specific photothermal/thermodynamic/chemodynamic synergistic Therapy.
Chen F; Zhang X; Wang Z; Xu C; Hu J; Liu L; Zhou J; Sun B
Biomater Sci; 2022 Oct; 10(20):5912-5924. PubMed ID: 36040793
[TBL] [Abstract][Full Text] [Related]
8. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Fenton-like Ion Delivery and Glutathione Depletion by MnO
Lin LS; Song J; Song L; Ke K; Liu Y; Zhou Z; Shen Z; Li J; Yang Z; Tang W; Niu G; Yang HH; Chen X
Angew Chem Int Ed Engl; 2018 Apr; 57(18):4902-4906. PubMed ID: 29488312
[TBL] [Abstract][Full Text] [Related]
10. Endo/exo-genous dual-stimuli responsive gold nanotetrapod-based nanoprobe for magnetic resonance imaging and enhanced multimodal therapeutics by amplifying·OH generation.
Shi Y; Zeng L; Pan Y; Zhang H; Wang Z; Shi Y; Wu A
Acta Biomater; 2022 Dec; 154():549-558. PubMed ID: 36243375
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-loaded mesoporous polydopamine nanoparticles capped with MnO
Zhang Y; Williams GR; Wang T; Zheng Y; Xu J; Nguyen VC; Yao L; Wang H; Zhu LM
Int J Pharm; 2024 May; 656():124093. PubMed ID: 38583822
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
13. Oxygen-supplementing mesoporous polydopamine nanosponges with WS
Wang Y; Song S; Lu T; Cheng Y; Song Y; Wang S; Tan F; Li J; Li N
Biomaterials; 2019 Nov; 220():119405. PubMed ID: 31408811
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional MnO
Wang Q; Qu B; Li J; Liu Y; Dong J; Peng X; Zhang R
ACS Appl Mater Interfaces; 2022 Feb; 14(4):4980-4994. PubMed ID: 35050589
[TBL] [Abstract][Full Text] [Related]
15. A mesoporous MnO
Zhang HL; Wang Y; Tang Q; Ren B; Yang SP; Liu JG
J Inorg Biochem; 2023 Apr; 241():112133. PubMed ID: 36708626
[TBL] [Abstract][Full Text] [Related]
16. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
[TBL] [Abstract][Full Text] [Related]
17. Amplification of oxidative stress with a hyperthermia-enhanced chemodynamic process and MTH1 inhibition for sequential tumor nanocatalytic therapy.
Song Q; Zhang Y; Deng X; Zhao H; Zhang Y; Li J; Chen W; Hu H; Zhang Y
J Mater Chem B; 2023 May; 11(17):3836-3850. PubMed ID: 36976579
[TBL] [Abstract][Full Text] [Related]
18. Fenton-like reaction and glutathione depletion by chiral manganese dioxide nanoparticles for enhanced chemodynamic therapy and chemotherapy.
Gao F; Sun M; Zhang J; Chang Y; Gao W; Ma G; Ma X; Guo Y
J Colloid Interface Sci; 2022 Jun; 616():369-378. PubMed ID: 35220185
[TBL] [Abstract][Full Text] [Related]
19. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation.
Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH
J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626
[TBL] [Abstract][Full Text] [Related]
20. Hollow mesoporous MnO
He H; Yang Q; Li H; Meng S; Xu Z; Chen X; Sun Z; Jiang B; Li C
Mikrochim Acta; 2021 Mar; 188(4):141. PubMed ID: 33774694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
